North America IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type, By End Use, By Technology (Immunoassays, Molecular Diagnostics, Hematology, and Others), By Country and Growth Forecast, 2023

List of Tables

The North America IVD In Cardiology And Neurology Market would witness market growth of 8.6% CAGR during the forecast period (2023-2030).

The US market dominated the North America IVD In Cardiology And Neurology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $8,663.4 million by 2030. The Canada market is experiencing a CAGR of 11.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2023 - 2030).

The market is a dynamic and vital segment within the broader healthcare landscape. The increasing prevalence of cardiovascular and neurological disorders has led to a significant surge in the application of IVD tests in the fields of cardiology and neurology. According to the data from the British Heart Foundation, by 2024, around 620 million individuals suffer from heart and circulatory diseases. Likewise, as per Statistics Canada, approximately 750,000 Canadians are living with Alzheimer's disease or another form of dementia. In 2022, Alzheimer's disease constituted the ninth most prevalent cause of mortality in Canada.

In addition, these conditions often necessitate precise and early diagnosis, so integrating IVD technologies has become indispensable for healthcare providers. An important factor in the widespread adoption of IVD tests in these specialties has been the growing consciousness among clinicians and patients regarding the critical nature of early detection and proactive management of cardiac and neurological disorders.

Canada's rising aging population is likely to significantly impact the expansion of In Vitro Diagnostics (IVD) in cardiology and neurology. As individuals age, the prevalence of chronic diseases and conditions associated with these medical specialties tends to increase. IVD plays a crucial role in the diagnosis, monitoring, and management of cardiovascular and neurological disorders, making it an essential component of healthcare for the elderly population. As per Statistics Canada, in 2022, there were 7,330,605 people aged 65 and older in Canada. Moreover, over 861,000 people aged 85 and older were counted in the 2021 Census, more than twice the number observed in the 2001 Census. Hence, rising CVD cases and the aging population in North America will assist in the growth of the market.

Based on Product Type, the market is segmented into Reagents & Consumables, Instruments, and Software & Services. Based on End Use, the market is segmented into Hospitals, Clinical Laboratories, and Others. Based on Technology, the market is segmented into Immunoassays, Molecular Diagnostics, Hematology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
Sysmex Corporation
Siemens Healthineers AG (Siemens AG)
Quest Diagnostics Incorporated
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter, Inc.)
Becton, Dickinson and Company
Natera, Inc.

North America IVD In Cardiology And Neurology Market Report Segmentation

By Product Type

Reagents & Consumables
Instruments
Software & Services

By End Use

Hospitals
Clinical Laboratories
Others

By Technology

Immunoassays
Molecular Diagnostics
Hematology
Others

By Country

US
Canada
Mexico
Rest of North America

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1North America IVD In Cardiology And Neurology Market, by Product Type
- 1.4.2North America IVD In Cardiology And Neurology Market, by End Use
- 1.4.3North America IVD In Cardiology And Neurology Market, by Technology
- 1.4.4North America IVD In Cardiology And Neurology Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.North America IVD In Cardiology And Neurology Market by Product Type

4.1North America Reagents & Consumables Market by Country
4.2North America Instruments Market by Country
4.3North America Software & Services Market by Country

Chapter 5.North America IVD In Cardiology And Neurology Market by End-use

5.1North America Hospitals Market by Country
5.2North America Clinical Laboratories Market by Country
5.3North America Others Market by Country

Chapter 6.North America IVD In Cardiology And Neurology Market by Technology

6.1North America Immunoassays Market by Country
6.2North America Molecular Diagnostics Market by Country
6.3North America Hematology Market by Country
6.4North America Others Market by Country

Chapter 7.North America IVD In Cardiology And Neurology Market by Country

7.1US IVD In Cardiology And Neurology Market
- 7.1.1US IVD In Cardiology And Neurology Market by Product Type
- 7.1.2US IVD In Cardiology And Neurology Market by End-use
- 7.1.3US IVD In Cardiology And Neurology Market by Technology
7.2Canada IVD In Cardiology And Neurology Market
- 7.2.1Canada IVD In Cardiology And Neurology Market by Product Type
- 7.2.2Canada IVD In Cardiology And Neurology Market by End-use
- 7.2.3Canada IVD In Cardiology And Neurology Market by Technology
7.3Mexico IVD In Cardiology And Neurology Market
- 7.3.1Mexico IVD In Cardiology And Neurology Market by Product Type
- 7.3.2Mexico IVD In Cardiology And Neurology Market by End-use
- 7.3.3Mexico IVD In Cardiology And Neurology Market by Technology
7.4Rest of North America IVD In Cardiology And Neurology Market
- 7.4.1Rest of North America IVD In Cardiology And Neurology Market by Product Type
- 7.4.2Rest of North America IVD In Cardiology And Neurology Market by End-use
- 7.4.3Rest of North America IVD In Cardiology And Neurology Market by Technology

Chapter 8.Company Profiles

8.1Thermo Fisher Scientific, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expenses
- 8.1.5Recent strategies and developments:
  - 8.1.5.1Partnerships, Collaborations, and Agreements:
- 8.1.6SWOT Analysis
8.2F. Hoffmann-La Roche Ltd.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
8.3Sysmex Corporation
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5SWOT Analysis
8.4Siemens Healthineers AG (Siemens AG)
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Partnerships, Collaborations, and Agreements:
- 8.4.6SWOT Analysis
8.5Quest Diagnostics Incorporated
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental Analysis
- 8.5.4Recent strategies and developments:
  - 8.5.4.1Acquisition and Mergers:
- 8.5.5SWOT Analysis
8.6Abbott Laboratories
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental and Regional Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
  - 8.6.5.1Partnerships, Collaborations, and Agreements:
  - 8.6.5.2Acquisition and Mergers:
- 8.6.6SWOT Analysis
8.7Bio-Rad laboratories, Inc.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5SWOT Analysis
8.8Danaher Corporation (Beckman Coulter)
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5SWOT Analysis
8.9Becton, Dickinson, and Company
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expense
- 8.9.5SWOT Analysis
8.10.Natera Inc.
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

LIST OF TABLES

TABLE 1North America IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 2North America IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 3North America IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 4North America IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 5North America Reagents & Consumables Market by Country, 2019 - 2022, USD Million
TABLE 6North America Reagents & Consumables Market by Country, 2023 - 2030, USD Million
TABLE 7North America Instruments Market by Country, 2019 - 2022, USD Million
TABLE 8North America Instruments Market by Country, 2023 - 2030, USD Million
TABLE 9North America Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 10North America Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 11North America IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 12North America IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 13North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 14North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 15North America Clinical Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 16North America Clinical Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 17North America Others Market by Country, 2019 - 2022, USD Million
TABLE 18North America Others Market by Country, 2023 - 2030, USD Million
TABLE 19North America IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 20North America IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 21North America Immunoassays Market by Country, 2019 - 2022, USD Million
TABLE 22North America Immunoassays Market by Country, 2023 - 2030, USD Million
TABLE 23North America Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 24North America Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 25North America Hematology Market by Country, 2019 - 2022, USD Million
TABLE 26North America Hematology Market by Country, 2023 - 2030, USD Million
TABLE 27North America Others Market by Country, 2019 - 2022, USD Million
TABLE 28North America Others Market by Country, 2023 - 2030, USD Million
TABLE 29North America IVD In Cardiology And Neurology Market by Country, 2019 - 2022, USD Million
TABLE 30North America IVD In Cardiology And Neurology Market by Country, 2023 - 2030, USD Million
TABLE 31US IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 32US IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 33US IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 34US IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 35US IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 36US IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 37US IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 38US IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 39Canada IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 40Canada IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 41Canada IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 42Canada IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 43Canada IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 44Canada IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 45Canada IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 46Canada IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 47Mexico IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 48Mexico IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 49Mexico IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 50Mexico IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 51Mexico IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 52Mexico IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 53Mexico IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 54Mexico IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 55Rest of North America IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 56Rest of North America IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 57Rest of North America IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 58Rest of North America IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 59Rest of North America IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 60Rest of North America IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 61Rest of North America IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 62Rest of North America IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 63Key Information - Thermo Fisher Scientific, Inc.
TABLE 64Key Information - F. Hoffmann-La Roche Ltd.
TABLE 65Key Information - Sysmex Corporation
TABLE 66Key Information - Siemens Healthineers AG
TABLE 67Key information - Quest Diagnostics Incorporated
TABLE 68Key Information - Abbott Laboratories
TABLE 69Key Information - Bio-Rad Laboratories, Inc.
TABLE 70Key Information - Danaher Corporation
TABLE 71Key Information - Becton, Dickinson and Company
TABLE 72Key Information - Natera Inc.

North America IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type, By End Use, By Technology (Immunoassays, Molecular Diagnostics, Hematology, and Others), By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents